Tuesday, April 2, 2013

Quality Appraisal of Diagnostic Accuracy Studies in Fine-Needle Aspiration Cytology: A Survey of Risk of Bias and Comparability

http://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2012-0199-RA


Quality Appraisal of Diagnostic Accuracy Studies in Fine-Needle Aspiration Cytology: A Survey of Risk of Bias and Comparability

Robert L. Schmidt MD, PhD, MBARachel E. Factor MDBenjamin L. Witt MDLester J. Layfield MD
From the Department of Pathology, University of Utah School of Medicine and ARUP Laboratories, Salt Lake City, Utah.
Context.—The quality of diagnostic accuracy studies is determined by 2 key factors: risk of bias and comparability. Bias can distort accuracy estimates and poor reporting impairs comparability. While diagnostic accuracy studies for fine-needle aspiration cytology (FNAC) are frequently published, the methodologic issues associated with this body of literature have never been reviewed.
Objective.—To assess the quality of design and reporting of diagnostic test accuracy studies in FNAC.
Data Sources.—Diagnostic accuracy studies were identified by a Medline (US National Library of Medicine) search. Sixty-four FNAC diagnostic test accuracy studies were randomly selected for structured review with the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) survey. Studies were divided between 2 time periods: 2000-2001 and 2009-2011.
Conclusions.—Diagnostic test accuracy studies of FNAC suffer from numerous deficiencies in study design, which negatively affect the reliability of accuracy estimates.

No comments:

Post a Comment